Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:loomic01

Total Results:

112


ADAM12: a potential target for the treatment of chronic wounds

Harsha, Asheesh; Stojadinovic, Olivera; Brem, Harold; Sehara-Fujisawa, Atsuko; Wewer, Ulla; Loomis, Cynthia A; Blobel, Carl P; Tomic-Canic, Marjana
Wound healing is a complex process involving multiple cellular events, including cell proliferation, migration, and tissue remodeling. A disintegrin and metalloprotease 12 (ADAM12) is a membrane-anchored metalloprotease, which has been implicated in activation-inactivation of growth factors that play an important role in wound healing, including heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) and insulin growth factor (IGF) binding proteins. Here, we report that expression of ADAM12 is fivefold upregulated in the nonhealing edge of chronic ulcers compared to healthy skin, based on microarrays of biopsies taken from five patients and from healthy controls (p = 0.013). The increase in ADAM12 expression in chronic ulcers was confirmed by quantitative real-time polymerase chain reaction (RT-PCR). Moreover, immunohistochemical analysis demonstrated a pronounced increase in the membranous and intracellular signal for ADAM12 in the epidermis of chronic wounds compared to healthy skin. These findings, coupled with our previous observations that lack of keratinocyte migration contributes to the pathogenesis of chronic ulcers, prompted us to evaluate how the absence of ADAM12 affects the migration of mouse keratinocytes. Skin explants from newborn ADAM12(-/-) or wild-type (WT) mice were used to quantify keratinocyte migration out of the explants over a period of 7 days. We found a statistically significant increase in the migration of ADAM12(-/-) keratinocytes compared to WT control (p = 0.0014) samples. Taken together, the upregulation of ADAM12 in chronic wounds and the increased migration of keratinocytes in the absence of ADAM12 suggest that ADAM12 is an important mediator of wound healing. We hypothesize that increased expression of ADAM12 in chronic wounds impairs wound healing through the inhibition of keratinocyte migration and that topical ADAM12 inhibitors may therefore prove useful for the treatment of chronic wounds
PMCID:2674959
PMID: 18604515
ISSN: 0946-2716
CID: 79473

STAT3 signaling and the hyper-IgE syndrome [Editorial]

Levy, David E; Loomis, Cynthia A
PMID: 17881746
ISSN: 1533-4406
CID: 93454

ADAM12: a potential target for treatment of chronic wounds [Meeting Abstract]

Harsha, A; Stojadinovic, O; Loomis, CA; Blobel, CP; Tomic-Canic, M
ISI:000245387800220
ISSN: 0022-202x
CID: 71618

Conditional ablation of epidermal En1 reveals a postnatal regulatory role [Meeting Abstract]

Pechar, D; Kraus, P; Loomis, CA
ISI:000242891500585
ISSN: 0022-202x
CID: 70334

The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling

Deckelbaum, Ron A; Majithia, Amit; Booker, Thomas; Henderson, Janet E; Loomis, Cynthia A
The membranous bones of the mammalian skull vault arise from discrete condensations of neural crest- and mesodermally-derived cells. Recently, a number of homeodomain transcription factors have been identified as critical regulators of this process. Here, we show that the homeoprotein engrailed 1 (EN1) is expressed during embryonic and perinatal craniofacial bone development, where it localizes to the skeletogenic mesenchyme, and, subsequently, to calvarial osteoblasts and osteoprogenitors. Mice lacking En1 exhibit generalized calvarial bone hypoplasia and persistent widening of the sutural joints. A reduction in calvarial membranous bone deposition and mineralization (osteopenia) is coupled to enhanced osteolytic resorption in En1 mutants. Consistent with these observations, expression of established osteoblast differentiation markers reveals that En1 function is required for both early and late phases of calvarial osteogenesis. Further analysis shows that EN1 regulates FGF signaling in calvarial osteoblasts. Moreover, EN1 indirectly influences calvarial osteoclast recruitment and bone resorption by regulating the expression of receptor activator of NFkappaB ligand (RANKL) in osteoblasts. Thus, during intramembranous bone formation, EN1 acts both cell autonomously and non-cell autonomously. In summary, this study identifies EN1 as a novel modulator of calvarial osteoblast differentiation and proliferation, processes that must be exquisitely balanced to ensure proper skull vault formation
PMID: 16319118
ISSN: 0950-1991
CID: 64195

Developmental analysis of nail development [Meeting Abstract]

Pechar, D; Zhao, Z; Loomis, CA
ISI:000220660500699
ISSN: 0022-202x
CID: 46580

Detailed characterization of eccrine gland development [Meeting Abstract]

Sanchez, L; Tong, C; Loomis, CA
ISI:000220660500718
ISSN: 0022-202x
CID: 46583

Fate map of mouse ventral limb ectoderm and the apical ectodermal ridge

Guo, Qiuxia; Loomis, Cynthia; Joyner, Alexandra L
The apical ectodermal ridge (AER) is a critical signaling center at the tip of the limb that promotes outgrowth. In mouse, formation of the AER involves a gradual restriction of AER gene expression from a broad ventral preAER domain to the tip of the limb, as well as progressive thickening of cells to form a multilayered epithelium. The AER is visible from embryonic day 10.5 to 13.5 (E10.5-E13.5) in the mouse forelimb. Previous short-term fate mapping studies indicated that, once a cell is incorporated into the AER, its descendents remain within the AER. In addition, some preAER cells appear to become incorporated into the ventral ectoderm. In the present study, we used an inducible CreER/loxP fate mapping approach in mouse to examine the long-term contribution of preAER cells to limb ventral ectoderm, as well as the ultimate fate of the mature AER cells. We used a CreER transgene that contains Msx2 regulatory sequences specific to the developing AER, and demonstrate by marking preAER cells that, at stage 2 of mouse limb bud development, the majority of the ventral ectoderm that protrudes from the body wall later covers only the paw. Furthermore, when Msx2-CreER-expressing preAER cells are marked after the onset of preAER gene expression, a similar domain of paw ventral ectoderm is marked at E16.5, in addition to the AER. Strikingly, mapping the long-term fate of cells that form the mature AER showed that, although this structure is indeed a distinct compartment, AER-derived cells are gradually lost after E12.5 and no cells remain by birth. A distinct dorsal/ventral border nevertheless is maintained in the ectoderm of the paw, with the distal-most border being located at the edge of the nail bed. These studies have uncovered new aspects of the cellular mechanisms involved in AER formation and in partitioning the ventral ectoderm in mouse limb
PMID: 14623239
ISSN: 0012-1606
CID: 44888

What syndrome is this? Nail-patella syndrome [Case Report]

Buddin, Deidre; Loomis, Cynthia; Shwayder, Tor; Chang, Mary Wu
PMID: 12383107
ISSN: 0736-8046
CID: 39389

Hair vs. eccrine gland: Timing and competition of skin appendage specification on the limb [Meeting Abstract]

Loomis, C; Tong, C; Kraus, P
ISI:000177428100499
ISSN: 0022-202x
CID: 55288